• FirefoxInstall the new Firefox »
  •  Dow Down 1.00% Nasdaq Down 0.75%

    More On AEZS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Aeterna Zentaris Inc. (AEZS)

    -NasdaqCM
    0.56 Down 0.23(29.63%) 11:40AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.79
    Open:0.55
    Bid:0.56 x 7000
    Ask:0.56 x 1200
    1y Target Est:1.52
    Beta:2.63
    Next Earnings Date:N/A
    Day's Range:0.49 - 0.56
    52wk Range:0.48 - 1.54
    Volume:11,079,249
    Avg Vol (3m):740,987
    Market Cap:36.47M
    P/E (ttm):N/A
    EPS (ttm):-0.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEZS

    Comparison

    Symbol% ChgMkt Cap
    AEZSDown 29.63%36.47M
    CELGDown 1.90%94.81B
    ENMDUp 1.79%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.55
    Quarterly EPS Est (Dec-14) :-0.16
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aeterna Zentaris Inc., a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback